NO884795D0 - Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette. - Google Patents

Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.

Info

Publication number: NO884795D0
Authority: NO; Norway
Prior art keywords: recombinant; preparing; procedure; human immunoglobulin; immunoglobulin
Prior art date: 1987-10-28

Application number

NO884795A

Other languages

English (en)

Other versions

NO884795L (no

Inventor

Linda J Harris

Leah A Lipsich

Michael A Walls

Original Assignee

Oncogen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-10-28

Filing date

1988-10-27

Publication date

1988-10-27

1988-10-27 Application filed by Oncogen filed Critical Oncogen

1988-10-27 Publication of NO884795D0 publication Critical patent/NO884795D0/no

1989-04-28 Publication of NO884795L publication Critical patent/NO884795L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO88884795A 1987-10-28 1988-10-27 Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette. NO884795L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11463287A	1987-10-28	1987-10-28
US25400488A	1988-09-16	1988-09-16

Publications (2)

Publication Number	Publication Date
NO884795D0 true NO884795D0 (no)	1988-10-27
NO884795L NO884795L (no)	1989-04-28

Family

ID=26812406

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO88884795A NO884795L (no)	1987-10-28	1988-10-27	Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.

Country Status (10)

Country	Link
EP (1)	EP0314161A1 (no)
JP (1)	JPH02138989A (no)
AU (2)	AU634151B2 (no)
DK (1)	DK597288A (no)
FI (1)	FI884924L (no)
IL (1)	IL88175A0 (no)
MY (1)	MY104344A (no)
NO (1)	NO884795L (no)
NZ (1)	NZ226694A (no)
PT (1)	PT88874B (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS63267295A (ja) *	1986-12-03	1988-11-04	Sumitomo Chem Co Ltd	ヒト抗体、抗体遺伝子及び対応する組換え体
US5610034A (en) *	1987-04-29	1997-03-11	Alko Group Ltd.	Immunoglobulin production by trichoderma
WO1991004336A1 (en) *	1989-09-19	1991-04-04	Centocor, Inc.	Method for improving human monoclonal antibody production
EP0462246A4 (en) *	1989-11-07	1992-11-25	Bristol-Myers Squibb Company	Oligomeric immunoglobulins
FI925724L (fi) *	1990-07-16	1992-12-16	Alko Ab Oy	Producering av immunoglobuliner i trichoderma
GB9022545D0 (en)	1990-10-17	1990-11-28	Wellcome Found	Culture medium
FI940144L (fi) *	1991-07-15	1994-01-12	Wellcome Found	Vasta-aineiden tuotanto
CA2078539C (en) *	1991-09-18	2005-08-02	Kenya Shitara	Process for producing humanized chimera antibody
CA2105618C (en) *	1992-09-07	2009-11-03	Kazuyasu Nakamura	Humanized antibodies to ganglioside gm2
US5939532A (en) *	1993-09-07	1999-08-17	Kyowa Hakko Kogyo Co., Ltd	Humanized antibodies to ganglioside GM2
US6042828A (en)	1992-09-07	2000-03-28	Kyowa Hakko Kogyo Co., Ltd.	Humanized antibodies to ganglioside GM2
US6130364A (en)	1995-03-29	2000-10-10	Abgenix, Inc.	Production of antibodies using Cre-mediated site-specific recombination
CN101275136A (zh)	2000-08-11	2008-10-01	麒麟医药株式会社	调节磷酸代谢,钙代谢,钙化和维生素d代谢的多肽及其编码dna
EP2009027B1 (en)	2001-04-27	2014-05-21	Kyowa Hakko Kirin Co., Ltd.	Anti-CD40 monoclonal antibody
JP4527982B2 (ja)	2001-12-28	2010-08-18	協和発酵キリン株式会社	線維芽細胞増殖因子−２３に対する抗体
CA2872136C (en)	2002-07-18	2017-06-20	Merus B.V.	Recombinant production of mixtures of antibodies
USRE47770E1 (en)	2002-07-18	2019-12-17	Merus N.V.	Recombinant production of mixtures of antibodies
AU2004242614B2 (en)	2003-05-30	2011-09-22	Merus N.V.	Fab library for the preparation of anti vegf and anti rabies virus fabs
US20100069614A1 (en)	2008-06-27	2010-03-18	Merus B.V.	Antibody producing non-human mammals
PL1707627T3 (pl) *	2003-12-25	2013-04-30	Kyowa Hakko Kirin Co Ltd	Mutant antagonistycznego przeciwciała anty-CD40
ES2646560T3 (es)	2004-01-20	2017-12-14	Merus N.V.	Mezclas de proteínas de unión
CA2579391C (en)	2004-09-06	2010-10-26	Kirin Beer Kabushiki Kaisha	Anti-a33 antibody
CA2644663A1 (en)	2006-03-23	2007-09-27	Kirin Pharma Kabushiki Kaisha	Agonist antibody to human thrombopoietin receptor
TWI390034B (zh)	2006-04-06	2013-03-21	Kyowa Hakko Kirin Co Ltd	Novel anti-CD98 antibody
GB0700133D0 (en)	2007-01-04	2007-02-14	Humabs Llc	Human cytomegalovirus neutralising antibodies and use thereof
US7947274B2 (en)	2007-01-04	2011-05-24	Humabs, LLC.	Human cytomegalovirus neutralising antibodies and use thereof
US7883705B2 (en)	2007-02-14	2011-02-08	Kyowa Hakko Kirin Co., Ltd.	Anti FGF23 antibody and a pharmaceutical composition comprising the same
PE20141434A1 (es)	2008-07-16	2014-10-22	Inst Research In Biomedicine	Anticuerpos neutralizantes de citomegalovirus humano
CN114163530B (zh)	2012-04-20	2025-04-29	美勒斯公司	用于产生免疫球蛋白样分子的方法和手段
BR112015000167B1 (pt)	2012-07-06	2021-11-23	Genmab B.V.	Proteína dimérica, proteína, composição, kit de partes e seus usos, bem como método para aumentar a oligomerização em solução de uma proteína dimérica compreendendo um primeiro e segundo polipeptídeo, cada um compreendendo pelo menos as regiões ch2 e ch3 de uma cadeia pesada de igg1 humana e proteína dimérica variante
ES2540753T3 (es) *	2012-09-24	2015-07-13	Lonza Biologics Plc.	Vectores de expresión que comprenden secuencias quiméricas de promotor y amplificador de citomegalovirus
SG10201705787VA (en)	2012-09-27	2017-08-30	Merus Nv	BISPECIFIC IgG ANTIBODIES AS T CELL ENGAGERS
ES2816624T3 (es)	2014-02-28	2021-04-05	Merus Nv	Anticuerpos que se unen a EGFR y ERBB3
SG11201607104RA (en)	2014-02-28	2016-09-29	Merus Nv	Antibody that binds erbb-2 and erbb-3
EA201890028A1 (ru)	2015-07-10	2018-08-31	Мерус Н.В.	Антитело, связывающее cd3 человека
HRP20210483T1 (hr)	2015-10-23	2021-07-09	Merus N.V.	Vezujuće molekule koje inhibiraju rast raka
KR20260006707A (ko)	2017-03-31	2026-01-13	메뤼스 엔.페.	NRG1 융합 유전자를 가지는 세포를 치료하기 위한 ErbB2 및 ErbB3 결합 이중특이적 항체
AU2018271157C1 (en)	2017-05-17	2021-11-18	Merus N.V.	Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancer
DK3665198T3 (da)	2017-08-09	2025-04-28	Merus Nv	Antistoffer, der binder egfr og cmet
TW201930351A (zh)	2017-10-06	2019-08-01	日商小野藥品工業股份有限公司	雙特異性抗體
TWI804572B (zh)	2018-02-09	2023-06-11	日商小野藥品工業股份有限公司	雙特異性抗體
TWI862565B (zh)	2019-04-04	2024-11-21	日商小野藥品工業股份有限公司	雙特異性抗體
TWI809286B (zh)	2019-07-05	2023-07-21	日商小野藥品工業股份有限公司	以pd-1/cd3雙特異性蛋白質所進行之血液性癌症治療
CN114174343A (zh)	2019-07-30	2022-03-11	小野药品工业株式会社	双特异性抗体
EP4011918A4 (en)	2019-08-08	2023-08-23	ONO Pharmaceutical Co., Ltd.	DUAL SPECIFIC PROTEIN
IL318949A (en)	2022-08-23	2025-04-01	Ono Pharmaceutical Co	Bispecific antibody

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4816567A (en) *	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
WO1987002671A1 (en) *	1985-11-01	1987-05-07	International Genetic Engineering, Inc.	Modular assembly of antibody genes, antibodies prepared thereby and use

1988
- 1988-10-25 NZ NZ226694A patent/NZ226694A/en unknown
- 1988-10-25 FI FI884924A patent/FI884924L/fi not_active IP Right Cessation
- 1988-10-26 AU AU24363/88A patent/AU634151B2/en not_active Ceased
- 1988-10-26 IL IL88175A patent/IL88175A0/xx unknown
- 1988-10-27 NO NO88884795A patent/NO884795L/no unknown
- 1988-10-27 JP JP63271910A patent/JPH02138989A/ja active Pending
- 1988-10-27 PT PT88874A patent/PT88874B/pt active IP Right Grant
- 1988-10-27 DK DK597288A patent/DK597288A/da not_active Application Discontinuation
- 1988-10-27 MY MYPI88001221A patent/MY104344A/en unknown
- 1988-10-28 EP EP88117998A patent/EP0314161A1/en not_active Ceased
1992
- 1992-10-01 AU AU26082/92A patent/AU2608292A/en not_active Abandoned

Also Published As

Publication number	Publication date
DK597288D0 (da)	1988-10-27
NO884795L (no)	1989-04-28
EP0314161A1 (en)	1989-05-03
AU634151B2 (en)	1993-02-18
NZ226694A (en)	1994-04-27
FI884924A7 (fi)	1989-04-29
PT88874A (pt)	1989-07-31
JPH02138989A (ja)	1990-05-28
IL88175A0 (en)	1989-06-30
FI884924L (fi)	1989-04-29
AU2608292A (en)	1992-12-17
FI884924A0 (fi)	1988-10-25
DK597288A (da)	1989-04-29
PT88874B (pt)	1994-01-31
MY104344A (en)	1994-03-31
AU2436388A (en)	1989-06-01

Publication	Publication Date	Title
NO884795D0 (no)	1988-10-27	Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.
NO872729D0 (no)	1987-06-30	Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
NO871025D0 (no)	1987-03-12	Polypeptid, dna og fremgangsmaate for fremstilling derav.
FI874819L (fi)	1987-11-02	Human rekombinant endotelcell vaextfaktor.
NO884733L (no)	1989-05-02	Roermuffe og fremgangsmaate til fremstilling av samme.
NO880434L (no)	1988-08-03	Bedoevelsesmiddel og fremgangsmaate for bruk derav.
NO853120L (no)	1986-02-10	Isfjell og fremgangsmaate for fremstilling av samme.
NO882766D0 (no)	1988-06-22	Katalysatorer og fremgangsmaate for deres fremstilling.
DK169987D0 (da)	1987-04-03	Human tumor-associated antigen, ca-ou1
NO864194L (no)	1987-08-17	Slipekorn og fremgangsmaate til fremstilling derav.
NO165421C (no)	1991-02-13	Fremgangsmaate og anordning for avskinning.
DK103889D0 (da)	1989-03-03	Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
DE3853743D1 (de)	1995-06-14	Rekombinanter menschlicher ADF.
NO873197D0 (no)	1987-07-30	Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
NO872587D0 (no)	1987-06-19	Forbedret limpreparat og fremgangsmaate for fremstilling av dette.
NO880292L (no)	1988-07-28	Fremgangsmaate for behandling av humle.
NO881713L (no)	1988-10-24	Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO853519L (no)	1986-03-11	Tannpleiemiddel og fremgangsmaate for fremstilling av dette.
NO912192D0 (no)	1991-06-07	Rekombinante dna og fremgangsmaate for fremstilling av chimere antistoffer.
NO157842C (no)	1988-06-01	Engangshanske og fremgangsmaate for fremstilling av samme.
NO845134L (no)	1985-06-27	Dialkanoyloksybenzyliden-dialkanoat og fremgangsmaate til fremstilling derav.
NO872765L (no)	1989-01-03	Beta-laktam-sammensetning, og framgangsmaate for framstilling av denne.
NO883363D0 (no)	1988-07-29	Nytt diosminderivat og fremgangsmaate for fremstilling av dette.
NO873274D0 (no)	1987-08-05	Tettet roerskjoet og fremgangsmaate for dannelse av denne.
IT8720970A0 (it)	1987-06-19	Procedimento per preparare carnitossi-carnitina e acetilcarnitossi-carnitina.